摘要 |
The invention relates to the use of peroxidated lipids, with a peroxidation rate of between 50 and 200 milli-equivalents per kilo, preferably between 50 and 150 milli-equivalents per kilo, for the preparation of a pharmaceutical composition intended for use in the treatment, by local application, of circulation deficiencies, in particular, of male sexual asthenia. |